Literature DB >> 12839828

Subcellular redistribution of the renal betaine transporter during hypertonic stress.

Stephen A Kempson1, Vaibhave Parikh, Lixuan Xi, Shaoyou Chu, Marshall H Montrose.   

Abstract

The betaine transporter (BGT1) protects cells in the hypertonic renal inner medulla by mediating uptake and accumulation of the osmolyte betaine. Transcriptional regulation plays an essential role in upregulation of BGT1 transport when renal cells are exposed to hypertonic medium for 24 h. Posttranscriptional regulation of the BGT1 protein is largely unexplored. We have investigated the distribution of BGT1 protein in live cells after transfection with BGT1 tagged with enhanced green fluorescent protein (EGFP). Fusion of EGFP to the NH2 terminus of BGT1 produced a fusion protein (EGFP-BGT) with transport properties identical to normal BGT1, as determined by ion dependence, inhibitor sensitivity, and apparent Km for GABA. Confocal microscopy of EGFP-BGT fluorescence in transfected Madin-Darby canine kidney (MDCK) cells showed that hypertonic stress for 24 h induced a shift in subcellular distribution from cytoplasm to plasma membrane. This was confirmed by colocalization with anti-BGT1 antibody staining. In fibroblasts, transfected EGFP-BGT caused increased transport in response to hypertonic stress. The activation of transport was not accompanied by increased expression of EGFP-BGT, as determined by Western blotting. Membrane insertion of EGFP-BGT protein in MDCK cells began within 2-3 h after onset of hypertonic stress and was blocked by cycloheximide. We conclude that posttranscriptional regulation of BGT1 is essential for adaptation to hypertonic stress and that insertion of BGT1 protein to the plasma membrane may require accessory proteins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12839828     DOI: 10.1152/ajpcell.00021.2003

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  8 in total

1.  Functional expression of γ-amino butyric acid transporter 2 in human and guinea pig airway epithelium and smooth muscle.

Authors:  Sarah Zaidi; George Gallos; Peter D Yim; Dingbang Xu; Joshua R Sonett; Reynold A Panettieri; William Gerthoffer; Charles W Emala
Journal:  Am J Respir Cell Mol Biol       Date:  2010-11-05       Impact factor: 6.914

2.  Characterization of endogenous betaine gamma-amino-n-butyric acid cotransporter glycoform and its hyperosmotic regulation in MDCK cells.

Authors:  Xue-Mei Zhang; Xi-Tao Wang; Hui Cai; Steve W Leung; Sandra E Guggino
Journal:  Pflugers Arch       Date:  2006-12-22       Impact factor: 3.657

3.  Hippocampal betaine/GABA transporter mRNA expression is not regulated by inflammation or dehydration post-status epilepticus.

Authors:  Nicole M Rowley; Misty D Smith; John G Lamb; Arne Schousboe; H Steve White
Journal:  J Neurochem       Date:  2011-02-09       Impact factor: 5.372

Review 4.  Osmotic regulation of renal betaine transport: transcription and beyond.

Authors:  Stephen A Kempson; Marshall H Montrose
Journal:  Pflugers Arch       Date:  2004-12       Impact factor: 3.657

5.  Acute inhibition of the betaine transporter by ATP and adenosine in renal MDCK cells.

Authors:  Stephen A Kempson; Jason M Edwards; Alyssa Osborn; Michael Sturek
Journal:  Am J Physiol Renal Physiol       Date:  2008-04-30

6.  Role of N-glycosylation in renal betaine transport.

Authors:  Eva S Schweikhard; Birgitta C Burckhardt; Friedericke Joos; Cristina Fenollar-Ferrer; Lucy R Forrest; Stephen A Kempson; Christine Ziegler
Journal:  Biochem J       Date:  2015-06-11       Impact factor: 3.857

Review 7.  The betaine/GABA transporter and betaine: roles in brain, kidney, and liver.

Authors:  Stephen A Kempson; Yun Zhou; Niels C Danbolt
Journal:  Front Physiol       Date:  2014-04-24       Impact factor: 4.566

8.  Hypotonic activation of the myo-inositol transporter SLC5A3 in HEK293 cells probed by cell volumetry, confocal and super-resolution microscopy.

Authors:  Joseph Andronic; Ryo Shirakashi; Simone U Pickel; Katherine M Westerling; Teresa Klein; Thorge Holm; Markus Sauer; Vladimir L Sukhorukov
Journal:  PLoS One       Date:  2015-03-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.